The introduction of the HRA and central governance review has caused some changes in the way in which commercial clinical trials are set up at our site. The below guidance is to help Sponsors ensure that set up of these studies is done quickly and efficiently. Due to our obligation to report clinical trial performance & delivery to the Department of Health quarterly, we are expected to record specific information to ensure adherence to national metrics .
Whether you are looking to include NUH as a site in your initial HRA study submission, or want to include the site after the study has received its HRA approval, we are here to support! At NUH we have a team of dedicated research project managers assigned to each of the Clinical Divisions at NUH. For each new submission, Sponsors and CROs will have a single point of contact for the set up and continued support for the study. In addition to this, we have a dedicated contracts team who review all contractual requirements by the Sponsor, and they can be contacted at Research Contracts
Whether you have a new study, want to add NUH as a site or a Commercial amendment, please refer to the relevant guidance document below: